Roanna Ruiz
Stock Analyst at Leerink Partners
(1.43)
# 3,627
Out of 4,988 analysts
452
Total ratings
46.3%
Success rate
-0.1%
Average return
Main Sectors:
Stocks Rated by Roanna Ruiz
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| XERS Xeris Biopharma Holdings | Reiterated: Buy | $9 → $16 | $8.20 | +95.12% | 36 | Sep 10, 2026 | |
| SPRY ARS Pharmaceuticals | Reiterated: Buy | $28 → $15 | $4.11 | +264.96% | 28 | Sep 8, 2026 | |
| AKBA Akebia Therapeutics | Downgraded: Hold | $7 → $1 | $0.9157 | +9.21% | 7 | Aug 7, 2026 | |
| VIR Vir Biotechnology | Reiterated: Buy | $19 | $10.60 | +79.25% | 34 | Aug 6, 2026 | |
| LNTH Lantheus Holdings | Downgraded: Hold | $99 → $103 | $100.55 | +1.94% | 54 | Aug 3, 2026 | |
| KARD Kardigan | Initiated Coverage: Buy | $37 | $16.64 | +122.36% | 1 | Jul 13, 2026 | |
| UTHR United Therapeutics | Reiterated: Buy | n/a | $494.63 | - | 26 | Jun 29, 2026 | |
| AQST Aquestive Therapeutics | Reiterated: Buy | $9 | $4.61 | +95.23% | 24 | May 15, 2026 | |
| CRMD CorMedix | Reiterated: Buy | $13 → $15 | $7.72 | +94.30% | 11 | May 15, 2026 | |
| IBIO iBio, Inc. | Reiterated: Buy | $5 → $6 | $1.28 | +368.75% | 3 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $3.54 | - | 1 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $68.78 | - | 30 | Jan 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 | $14.95 | +7.02% | 1 | Nov 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $7 → $9 | $12.20 | -26.23% | 37 | Oct 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1.00 → $2.00 | $0.89 | n/a | 8 | Aug 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1 | $2.05 | n/a | 17 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $107 → $44 | $22.49 | n/a | 27 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $11 | $3.42 | n/a | 11 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $10 | $13.63 | n/a | 30 | Jul 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $156.47 | n/a | 2 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $5 → $4 | $5.33 | n/a | 23 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $25 | $5.24 | n/a | 22 | May 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $23 | $110.29 | n/a | 6 | Jan 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $80 | $0.000001 | n/a | 13 | Dec 20, 2022 |
Xeris Biopharma Holdings
Sep 10, 2026
Reiterated: Buy
Price Target: $9 → $16
Current: $8.20
Upside: +95.12%
ARS Pharmaceuticals
Sep 8, 2026
Reiterated: Buy
Price Target: $28 → $15
Current: $4.11
Upside: +264.96%
Akebia Therapeutics
Aug 7, 2026
Downgraded: Hold
Price Target: $7 → $1
Current: $0.9157
Upside: +9.21%
Vir Biotechnology
Aug 6, 2026
Reiterated: Buy
Price Target: $19
Current: $10.60
Upside: +79.25%
Lantheus Holdings
Aug 3, 2026
Downgraded: Hold
Price Target: $99 → $103
Current: $100.55
Upside: +1.94%
Kardigan
Jul 13, 2026
Initiated Coverage: Buy
Price Target: $37
Current: $16.64
Upside: +122.36%
United Therapeutics
Jun 29, 2026
Reiterated: Buy
Price Target: n/a
Current: $494.63
Upside: -
Aquestive Therapeutics
May 15, 2026
Reiterated: Buy
Price Target: $9
Current: $4.61
Upside: +95.23%
CorMedix
May 15, 2026
Reiterated: Buy
Price Target: $13 → $15
Current: $7.72
Upside: +94.30%
iBio, Inc.
May 15, 2026
Reiterated: Buy
Price Target: $5 → $6
Current: $1.28
Upside: +368.75%
Feb 25, 2026
Reiterated: Buy
Price Target: n/a
Current: $3.54
Upside: -
Jan 13, 2026
Reiterated: Buy
Price Target: n/a
Current: $68.78
Upside: -
Nov 18, 2025
Reiterated: Buy
Price Target: $16
Current: $14.95
Upside: +7.02%
Oct 1, 2025
Reiterated: Hold
Price Target: $7 → $9
Current: $12.20
Upside: -26.23%
Aug 25, 2025
Reiterated: Hold
Price Target: $1.00 → $2.00
Current: $0.89
Upside: n/a
Aug 7, 2025
Reiterated: Hold
Price Target: $1
Current: $2.05
Upside: n/a
Aug 7, 2025
Reiterated: Buy
Price Target: $107 → $44
Current: $22.49
Upside: n/a
Aug 5, 2025
Reiterated: Buy
Price Target: $10 → $11
Current: $3.42
Upside: n/a
Jul 31, 2025
Reiterated: Hold
Price Target: $10
Current: $13.63
Upside: n/a
Mar 6, 2025
Reiterated: Buy
Price Target: n/a
Current: $156.47
Upside: n/a
May 14, 2024
Reiterated: Hold
Price Target: $5 → $4
Current: $5.33
Upside: n/a
May 7, 2024
Reiterated: Hold
Price Target: $25
Current: $5.24
Upside: n/a
Jan 22, 2024
Reiterated: Hold
Price Target: $23
Current: $110.29
Upside: n/a
Dec 20, 2022
Reiterated: Hold
Price Target: $80
Current: $0.000001
Upside: n/a